Choucair K, Page SJ, Mattar BI, Dakhil CS, et al. Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World Experience. Clin Breast Cancer 2022 Nov 23:S1526-8209(22)00261.
PMID: 36566135